Microagulhamento isolado ou associado a terapias adjuvantes no tratamento de cicatrizes atróficas de acne: Uma revisão integrativa
Year: 2026
Type: article
Study design: Systematic Review
Abstract: Atrophic acne scars are persistent skin changes that can affect appearance, self-esteem, and quality of life. Microneedling stimulates tissue repair and collagen remodeling and can be used alone or combined with adjuvant therapies. This study aimed to analyze, based on recent scientific literature, whether microneedling combined with adjuvant therapies yields better clinical outcomes than microneedling alone in the treatment of atrophic acne scars. An integrative literature review guided by the PICO strategy was conducted in PubMed/MEDLINE, BVS, and SciELO, including clinical trials published between 2018 and 2026 that directly compared both approaches. Eight studies, conducted in Egypt and India, were included; they evaluated combinations with platelet-rich plasma (PRP), chemical peels, and hyaluronic acid. All of them reported a reduction in scar severity with both microneedling alone and combined treatments. Trichloroacetic acid and glycolic acid peels outperformed microneedling alone in the two studies that tested them. For PRP, four studies showed additional benefit, while two found no statistically significant difference. With hyaluronic acid, the combination produced more good and very good responses, with no difference in patient satisfaction. Small samples, heterogeneous protocols, and short follow-up limit the strength of these conclusions. Microneedling alone is an effective option, and some combinations may enhance its results, but there is no evidence of consistent superiority for all of them, which reinforces the need to individualize treatment and to conduct more standardized clinical trials with longer follow-up.
Source: Research Society and Development
Institution: Centro Universitário Una
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7236113188
